Showing results (311-320 of 350) with videos related to
Sort By:
Pageof 35
Annals of the American Thoracic Society|September 8, 2025
Neutrophil-to-Lymphocyte Ratio as a Biomarker in Clinically Stable Chronic Obstructive Pulmonary Disease: SPIROMICS CohortDaniel T Hoesterey, Hong Dang, Daniela Markovic, et al.Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 19, 2024
Design of the SPIROMICS Study of Early COPD Progression: SOURCE StudyJeffrey L Curtis, Lori A Bateman, Susan Murray, et al.Medrxiv : the Preprint Server for Health Sciences|August 16, 2024
Dynamic and prognostic proteomic associations with FEV1 decline in chronic obstructive pulmonary diseaseLisa Ruvuna, Kahkeshan Hijazi, Daniel E Guzman, et al.American Journal of Respiratory and Critical Care Medicine|June 27, 2024
Dysanapsis Genetic Risk Predicts Lung Function Across the LifespanCatherine L Debban, Amirthagowri Ambalavanan, Auyon Ghosh, et al.BMC Medical Genomics|August 3, 2014
Integrated genome-wide association, coexpression network, and expression single nucleotide polymorphism analysis identifies novel pathway in allergic rhinitisSupinda Bunyavanich, Eric E Schadt, Blanca E Himes, et al.American Journal of Respiratory and Critical Care Medicine|July 31, 2023
A Polygenic Risk Score for Idiopathic Pulmonary Fibrosis and Interstitial Lung AbnormalitiesMatthew Moll, Anna L Peljto, John S Kim, et al.The Pharmacogenomics Journal|September 13, 2018
A genome-wide association and admixture mapping study of bronchodilator drug response in African Americans with asthmaMelissa L Spear, Donglei Hu, Maria Pino-Yanes, et al.The Lancet. Respiratory Medicine|July 11, 2020
Chronic obstructive pulmonary disease and related phenotypes: polygenic risk scores in population-based and case-control cohortsMatthew Moll, Phuwanat Sakornsakolpat, Nick Shrine, et al.American Journal of Respiratory and Critical Care Medicine|August 25, 2016
Inflammatory and Comorbid Features of Patients with Severe Asthma and Frequent ExacerbationsLoren C Denlinger, Brenda R Phillips, Sima Ramratnam, et al.Journal of Biopharmaceutical Statistics|September 17, 2020
The precision interventions for severe and/or exacerbation-prone asthma (PrecISE) adaptive platform trial: statistical considerationsAnastasia Ivanova, Elliot Israel, Lisa M LaVange, et al.Pageof 35